Tizona Elects Daniel K. Spiegelman to Its Board of Directors
SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Tizona Therapeutics, Inc., a privately held immunotherapy company, today announced the appointment of Daniel K. Spiegelman to its Board of Directors. Mr. Spiegelman is currently Executive Vice …